MRL Ventures Fund LLC 13D and 13G filings for Entrada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-08 12:03 pm Purchase |
2021-12-31 | 13G | Entrada Therapeutics, Inc. TRDA |
MRL Ventures Fund LLC | 1,739,768 5.600% |
1,739,768 (New Position) |
Filing |